OR WAIT null SECS
November 24, 2022
Case history can give clues to a patient’s risk of developing diabetic eye disease.
November 21, 2022
The ERG is a game changer for patients with diabetes.
October 28, 2022
Sherrol A. Reynolds, OD, FAAO, shares highlights from her discussion, "The OD's role in addressing silent killers: diabetes, hypertension, and dyslipidemia," which she presented during this year's American Academy of Optometry annual meeting.
October 26, 2022
Anthony DeWilde, OD, FAAO, shares highlights from his AAOpt presentation, "Anti-VEGF and the eye: Past, present and future."
October 13, 2022
World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.
In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.
October 03, 2022
The data analysis showed that the macular thickness decreased across all time periods and in all macular regions for all tertiles.
September 08, 2022
OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone that has the potential to be the first topical eye drop and non-invasive treatment for DME.
August 27, 2022
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
August 26, 2022
Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient
Alcon completes acquisition of Aerie Pharmaceuticals
Words matter: Update how you talk to your patients
FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes
